Latest Aspira Pathlab stock price
Aspira Pathlab P/E Ratio
ASPIRA • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
28.33
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
28.33
Current Price
₹63.33
EPS (TTM)
₹1.97
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
51.27
Sector Median
51.69
Sector Rank
#3 of 10
Sector Percentile
30.0%
Earnings Breakdown (TTM)
TTM EPS
₹1.54
Mar 2025
₹0.66
Jun 2025
₹0.41
Key P/E Ratio Insights for Aspira Pathlab
- Stock appears overvalued with PE of 28.33, suggesting caution for new investments
- Trading at discount to sector average PE of 51.27
View the ASPIRA equity price for detailed stock performance.
Related Pages for Aspira Pathlab
Additional stock information and data for ASPIRA
Sector P/E Ratio Comparison
Comparing Aspira Pathlab with other companies in Healthcare Services sector
Sector Average
51.27
Sector Median
51.69
Lowest P/E
20.28
Highest P/E
87.39
Companies
10
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Medinova Diagnostic Serv… | MEDINOV | 20.28 | ₹44 | Moderate |
| GPT Healthcare | GPTHEALTH | 25.82 | ₹1,156 | High |
| Artemis Medicare Services | ARTEMISMED | 45.1 | ₹4,297 | High |
| Jupiter Life Line Hospit… | JLHL | 45.83 | ₹9,036 | High |
| Dr. Lal Path Labs | LALPATHLAB | 45.9 | ₹24,389 | High |
| Rainbow Childrens Medica… | RAINBOW | 51.69 | ₹13,115 | High |
| Thyrocare Technologies | THYROCARE | 58.83 | ₹7,384 | High |
| Apollo Hospitals | APOLLOHOSP | 61.11 | ₹105,653 | High |
| Krishna Institute of Med… | KIMS | 70.79 | ₹25,041 | High |
| Aster DM Healthcare | ASTERDM | 87.39 | ₹32,416 | High |